CYT003-QbG10: Preliminary Phase IIa data

CYTN said preliminary Phase IIa data in patients with allergic rhinitis due to grass pollen allergy suggests that QbG10 alone could be used as a vaccine. Previously, QbG10 was being developed as an ad...